Impact on Share Price of Favorable Issuance Terms for Series 4 Stock Acquisition Rights
First written in FY2018. 2 of 4 entries say "Restated". Latest entry: FY2020.
No other company in this theme has enough history to compare yet.
- FY2020MitigatedAnnual report
「Decrease due to the exercise of the fourth series of stock acquisition rights 105,000,000 shares」
The exercise of the fourth series of stock acquisition rights has been completed, reducing the potential impact of the previous issue and exercise terms on future share prices from the level when unexercised rights remained outstanding. - FY2019-Q2RestatedAnnual report
「Issue price of shares and amount of capital to be included when shares are issued through the exercise of stock acquisition rights (yen) * Issue price 2 Amount of capital to be included 1」
The company continued to disclose the terms of an issue price of ¥2 and an amount of capital to be included of ¥1 for the fourth series of stock acquisition rights. - FY2019-Q1RestatedAnnual report
「Issue price of shares and amount of capital to be included when shares are issued through the exercise of stock acquisition rights (yen) * Issue price 2 Amount of capital to be included 1」
The company continued to disclose an issue price of ¥2 and an amount of capital to be included of ¥1 for shares issued through the exercise of stock acquisition rights. - FY2018First statedAnnual report
「As a result, the issue price was ¥570 per stock acquisition right, equivalent to ¥5.7 per share. However, following discussions with the intended allottee, the issue price was set at ¥4.5 per stock acquisition right and the exercise price at ¥2 per share. The company therefore determined that the rights would be issued on terms particularly favorable to the intended allottee, which could have a significant impact on future share price movements.」
The company identifies as a risk the possibility of a significant impact on future share price movements resulting from setting issue and exercise prices on favorable terms different from the value calculated by an independent valuation institution.